Creation of active bio-components and nano-transport factors for solving critical skin problems

NanoBioRem Ltd. is an innovative company established in 2016, with main subject of activity in the field of research and development (R amp; D) in biotechnology and nanotechnology. The team of the company has a considerable experience in R amp; D and innovations. The aim of the current project is to develop a prototype of a highly active serum based on the linking of the isolated bio-components of the snail slime to the active nanotransport factors /nanodiamonds /, focused at solving critical skin problems with important medical, cosmetic and social significance. Solving the critical skin problems / wounds, injuries of any kind / is an important health and social factor, providing the extension and improvement of the active part of human life. Offering of a means for treatment of skin problems, based on bio and nanotechnology, combined with the natural origin of the material, puts the developed product in the top positions of significance and innovation. Under the project will be created innovations in biotechnology /proteomics/, in nanotechnology /nanotransport factors/ and also in the products control /mass spectroscopy, fluorescence analysis, enzymological detoxification control, electronic microscopic methods, etc./. Development of a serum from active bio-components and active nanotransport factors will cause a triple synergetic effect – penetrating, detoxicating and recovering. Additionally, it will have also an antibacterial effect due to the antibacterial properties of the treated bio-components of the snail slime. The project is entirely focused at market realization of a product in thematic area “Industry for healthy life and biotechnologies” of ISIS. The development of the innovative product will improve the competitiveness and innovation capacity of the company and will also create a lot of new business opportunities of NanoBioRem Ltd.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 31 Jul, 2017
End date 11 Oct, 2019
Contract date 31 Jul, 2017
View in UMIS

Beneficiary

Financial information

Total cost 433,970.00
Grant 390,573.00
Self finance 43,397.00
Total paid 384,562.30
EU participation percent 85.0%

Location